Vibramycin and Pravachol drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Vibramycin and Pravachol. Common interactions include gastritis among females and nausea among males.

The phase IV clinical study analyzes what interactions people who take Vibramycin and Pravachol have. It is created by eHealthMe based on reports of 13 people who take Vibramycin and Pravachol from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.

With medical big data and AI algorithms, eHealthMe enables everyone to run phase IV clinical trial to detect adverse drug outcomes and monitor effectiveness. Our original studies have been referenced on 600+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Most recently, phase IV clinial trails for COVID 19 vaccines have been added, check here.



On May, 22, 2022

13 people who take Vibramycin and Pravachol together, and have interactions are studied.


What is Vibramycin?

Vibramycin has active ingredients of doxycycline. It is often used in acne. eHealthMe is studying from 1,666 Vibramycin users for its effectiveness, alternative drugs and more.

What is Pravachol?

Pravachol has active ingredients of pravastatin sodium. It is often used in high blood cholesterol. eHealthMe is studying from 23,466 Pravachol users for its effectiveness, alternative drugs and more.

Number of Vibramycin and Pravachol reports submitted per year:

Vibramycin and Pravachol drug interactions.

Common Vibramycin and Pravachol drug interactions by gender *:

female:

  1. Gastritis
  2. Gastrooesophageal reflux disease
  3. Heart rate irregular
  4. Helicobacter test positive
  5. Hemiparesis
  6. Hyperparathyroidism secondary
  7. Hypertension
  8. Hyperthyroidism
  9. Hypoaesthesia
  10. Hyponatraemia

male:

  1. Nausea
  2. Vomiting
  3. Dehydration
  4. Epistaxis
  5. Gait abnormal
  6. Glycosuria present
  7. Haematocrit decreased
  8. Haemoglobin decreased
  9. Hydronephrosis
  10. Hypotension

Common Vibramycin and Pravachol drug interactions by age *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

  1. Hypertension
  2. Hypomagnesaemia
  3. Mental status changes
  4. Nausea
  5. Palpitations
  6. Presyncope
  7. Pyrexia
  8. Rash
  9. Renal failure
  10. Respiratory tract infection

60+:

  1. Dehydration
  2. Fatigue
  3. Drug ineffective
  4. Epistaxis
  5. Gait abnormal
  6. Glycosuria present
  7. Haematocrit decreased
  8. Haemoglobin decreased
  9. Hydronephrosis
  10. Hypotension

Common conditions people have *:

  1. Nausea (feeling of having an urge to vomit): 3 people, 23.08%
  2. Stress And Anxiety: 3 people, 23.08%
  3. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 3 people, 23.08%
  4. Bronchopulmonary Aspergillosis (lung disorder caused by aspergillus fungi): 2 people, 15.38%
  5. Gastric Ulcer (stomach ulcer): 2 people, 15.38%
  6. Pain: 2 people, 15.38%
  7. High Blood Pressure: 2 people, 15.38%
  8. Chest Pain: 1 person, 7.69%
  9. Breathing Difficulty: 1 person, 7.69%
  10. Headache (pain in head): 1 person, 7.69%

* Approximation only. Some reports may have incomplete information.

Do you take Vibramycin and Pravachol?

Personalize this study to your gender and age

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.



Related publications that referenced our studies

Related studies

Alternative drugs to, pros and cons of the 2 drugs:

Browse all drug interactions of Vibramycin and Pravachol:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Vibramycin interactions:

Browse all interactions between Vibramycin and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Pravachol interactions:

Browse all interactions between Pravachol and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on doxycycline and pravastatin sodium (the active ingredients of Vibramycin and Pravachol, respectively), and Vibramycin and Pravachol (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe: